Michael Reardon and Lars Søndergaard pay tribute to the life and legacy of Alain Cribier—the pioneer of transcatheter aortic valve implantation (TAVI) who died in February at the age of 79.
Reardon and Søndergaard discuss the world-changing impact of Cribier’s work, including how TAVI has revolutionised the treatment of aortic disease, and their recollections of him as an academic and human being.
Cribier who had been the director of cardiology at Charles Nicolle Hospital, University of Rouen (Rouen, France), was recognised globally for his role in the world’s first TAVI procedure in 2002.
